Translations:Discovery and development of gliflozins/1/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,847 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 09:56, 14 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Discovery and development of gliflozins)
[[Gliflozin]]s are a class of drugs in the treatment of [[type 2 diabetes]] (T2D). They act by inhibiting [[sodium/glucose cotransporter 2]] (SGLT-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[glucosuria]]. The mechanism of action is insulin independent.

Gliflozins are a class of drugs in the treatment of type 2 diabetes (T2D). They act by inhibiting sodium/glucose cotransporter 2 (SGLT-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents glucose from going into blood circulation by promoting glucosuria. The mechanism of action is insulin independent.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Discovery_and_development_of_gliflozins/1/en&oldid=114387"